Jung Hyun Boo
Overview
Explore the profile of Jung Hyun Boo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
213
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim C, Nam D, Park S, Song H, Hong H, Boo J, et al.
Neurobiol Aging
. 2012 Apr;
34(1):275-85.
PMID: 22503002
Deposition of β-amyloid (Aβ) as senile plaques and disrupted glucose metabolism are two main characteristics of Alzheimer's disease (AD). It is unknown, however, how these two processes are related in...
2.
Lee J, Boo J, Ryu H
Adv Drug Deliv Rev
. 2009 Sep;
61(14):1316-23.
PMID: 19716395
Mitochondria are the power engine generating biochemical energy in the cell. Mitochondrial dysfunction and bioenergy deficiency is closely linked to the pathogenesis of neurodegenerative disorders. Mitochondria play a variety of...
3.
Boo J, Sohn J, Kim J, Song H, Mook-Jung I
Biochem Biophys Res Commun
. 2008 Jun;
372(4):913-7.
PMID: 18538664
Beta amyloid peptide is generated from amyloid precursor protein (APP) by proteolytic cleavage of beta- and gamma-secretases, and plays a critical role in the pathogenesis of Alzheimer's disease. Since gamma-secretase...
4.
Lee P, Hwang E, Hong H, Boo J, Mook-Jung I, Huh K
Neurochem Res
. 2006 Jun;
31(6):821-7.
PMID: 16794858
The nature of the association between ischemic stroke and Alzheimer's disease (AD) at the cellular and molecular level is still unknown. We evaluated the effect of ischemic neuronal insults on...
5.
Shin S, Lee S, Boo J, Kim M, Yoon Y, Kim S, et al.
Proteomics
. 2004 Sep;
4(11):3359-68.
PMID: 15378736
Alzheimer's disease (AD) is an age-related neurodegenerative disorder that is characterized by the extracellular deposition of beta-amyloid and intracellular hyperphosphorylation of tau in the cortex and hippocampus of the brain....
6.
Lee W, Boo J, Jung M, Park S, Kim Y, Kim S, et al.
Mol Cell Neurosci
. 2004 Jun;
26(2):222-31.
PMID: 15207847
A putative protein kinase C (PKC) pseudosubstrate domain in beta amyloid (Abeta) suggests a potential interaction between Abeta and PKC. In this study, we investigated whether and how Abeta interacts...
7.
Bang O, Hong H, Kim D, Kim H, Boo J, Huh K, et al.
Neurobiol Dis
. 2004 Jun;
16(1):21-8.
PMID: 15207258
Estrogen is beneficial to patients with Alzheimer's disease (AD) but has a limited clinical use due to its proliferative and oncogenic effects on non-neuronal cells responsive to estrogen. In an...
8.
Park I, Hwang E, Hong H, Boo J, Oh S, Lee J, et al.
Neurobiol Aging
. 2003 Jul;
24(5):637-43.
PMID: 12885571
A recent clinical study showed that statins, which are inhibitors of cholesterol biosynthesis pathway, reduced the prevalence of Alzheimer's disease (AD). Animal studies that have employed high cholesterol diet indicate...